阿立哌唑导致的激越加重：多巴胺部分激动作用的不良反应？ - Suppr

Suppr

超能文献

Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism?

作者信息

DeQuardo John R

出版信息

J Clin Psychiatry. 2004 Jan;65(1):132-3. doi: 10.4088/jcp.v65n0122b.

DOI:10.4088/jcp.v65n0122b

PMID:14976671

Abstract

摘要

相似文献

Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism?

J Clin Psychiatry. 2004 Jan;65(1):132-3. doi: 10.4088/jcp.v65n0122b.

Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?

Ann Pharmacother. 2003 May;37(5):738-40. doi: 10.1345/aph.1D014.

Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole.

J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):481-2. doi: 10.1176/jnp.2007.19.4.481.

Aripiprazole as a dopamine partial agonist: positive and negative effects.

J Clin Psychopharmacol. 2006 Feb;26(1):101-3. doi: 10.1097/01.jcp.0000196417.44847.0b.

Aripiprazole: a new atypical antipsychotic drug.

Ann Pharmacother. 2003 May;37(5):687-94. doi: 10.1345/aph.1C297.

Aripiprazole's receptor pharmacology and extrapyramidal side effects.

Am J Psychiatry. 2008 Mar;165(3):398; author reply 398-9. doi: 10.1176/appi.ajp.2007.07091513.

Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents.

Prescrire Int. 2009 Dec;18(104):251.

Aripiprazole-induced tardive dyskinesia: the role of tamoxifen.

Am J Psychiatry. 2007 Sep;164(9):1436-7. doi: 10.1176/appi.ajp.2007.07030469.

Aripiprazole: pharmacology, efficacy, safety and tolerability.

Expert Rev Neurother. 2005 May;5(3):297-307. doi: 10.1586/14737175.5.3.297.

Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole.

Am J Psychiatry. 2007 Sep;164(9):1437-8. doi: 10.1176/appi.ajp.2007.07020363.

引用本文的文献

The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?

Int Clin Psychopharmacol. 2022 Nov 1;37(6):263-275. doi: 10.1097/YIC.0000000000000417. Epub 2022 Jul 12.

Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia.

Curr Neuropharmacol. 2021;19(12):2214-2226. doi: 10.2174/1570159X19666210125152815.

Polypharmacy in pediatric patients and opportunities for pharmacists' involvement.

Integr Pharm Res Pract. 2015 Aug 21;4:113-126. doi: 10.2147/IPRP.S64535. eCollection 2015.

Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia.

J Psychopharmacol. 2015 Apr;29(4):383-9. doi: 10.1177/0269881115570083. Epub 2015 Mar 3.

A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder.

Psychopharmacology (Berl). 2013 Jul;228(2):175-85. doi: 10.1007/s00213-013-3154-1. Epub 2013 Jun 5.

A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder.

Neuropsychiatr Dis Treat. 2006 Dec;2(4):427-43. doi: 10.2147/nedt.2006.2.4.427.

Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.

CNS Drug Rev. 2004 Winter;10(4):317-36. doi: 10.1111/j.1527-3458.2004.tb00030.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验